Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin - Contacts and Locations

Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin

This study is currently recruiting participants.

Study NCT00652119. Last updated on March 31, 2008. Information provided by M.D. Anderson Cancer Center

Please refer to this study by its ClinicalTrials.gov identifier: NCT00652119

Contacts


Contact: Judith Wolf, MD	713-792-7310

Locations


United States, Maryland
	Johns Hopkins Hospital	Recruiting
	Baltimore, Maryland, United States, 21287

United States, Massachusetts
	Massachusetts General Hospital	Recruiting
	Boston, Massachusetts, United States, 02114

United States, Pennsylvania
	Fox Chase Cancer Center	Recruiting
	Philadelphia, Pennsylvania, United States, 19111

United States, Texas
	U.T.M.D. Anderson Cancer Center	Recruiting
	Houston, Texas, United States, 77030
	Principal Investigator: Judith Wolf, MD

United States, Washington
	University of Washington	Recruiting
	Seattle, Washington, United States, 98195

Sponsors and Collaborators

M.D. Anderson Cancer Center

Genentech

Investigators


Principal Investigator:	Judith Wolf, MD	U.T.M.D. Anderson Cancer Center